Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Vues
• 08/04/23
0
0
Intégrer
administrator
Les abonnés
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires